DLG4 and Alzheimer disease: Our results showed that subjects with AD on average had markedly increased PSD-95 and SNAP-25 CSF levels compared to both healthy controls and subjects with other neurodegenerative diseases, further promoting these two proteins as biomarkers for synaptic dysfunction in AD.